Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology (HK:1061)
:1061
RESEARCH TOOLSreports
1061 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$2.15 - HK$5.60
Previous CloseN/A
Volume76.00K
Average Volume (3M)1.07M
Market Cap
HK$2.90B
Enterprise ValueHK$1.31B
Total Cash (Recent Filing)HK$560.74M
Total Debt (Recent Filing)HK$187.04M
Price to Earnings (P/E)9.4
Beta0.48
Next Earnings
Aug 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2025Dividend Yield3.09%
Share Statistics
EPS (TTM)0.26
Shares Outstanding567,006,000
10 Day Avg. Volume952,200
30 Day Avg. Volume1,065,946
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$5.00Price Target Upside-3.47% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Essex Bio-Technology News
1061 FAQ
What was Essex Bio-Technology ’s price range in the past 12 months?
Essex Bio-Technology lowest stock price was HK$2.15 and its highest was HK$5.60 in the past 12 months.
What is Essex Bio-Technology ’s market cap?
Essex Bio-Technology ’s market cap is HK$2.90B.
When is Essex Bio-Technology ’s upcoming earnings report date?
Essex Bio-Technology ’s upcoming earnings report date is Aug 26, 2025 which is in 19 days.
How were Essex Bio-Technology ’s earnings last quarter?
Essex Bio-Technology released its earnings results on Mar 26, 2025. The company reported HK$0.264 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.264.
Is Essex Bio-Technology overvalued?
According to Wall Street analysts Essex Bio-Technology ’s price is currently Overvalued.
Does Essex Bio-Technology pay dividends?
Essex Bio-Technology pays a Semiannually dividend of HK$0.06 which represents an annual dividend yield of 3.09%. See more information on Essex Bio-Technology dividends here
What is Essex Bio-Technology ’s EPS estimate?
Essex Bio-Technology ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology have?
Essex Bio-Technology has 567,006,000 shares outstanding.
What happened to Essex Bio-Technology ’s price movement after its last earnings report?
Essex Bio-Technology reported an EPS of HK$0.264 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.717%.
Which hedge fund is a major shareholder of Essex Bio-Technology ?
Currently, no hedge funds are holding shares in HK:1061
Essex Bio-Technology Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
HK$5.00 (-3.47% Downside)
HK$5.00 (-3.47% Downside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
124.31%
12-Months-Change
Fundamentals
Return on Equity
15.18%
Trailing 12-Months
Asset Growth
5.50%
Trailing 12-Months
Company Description
Essex Bio-Technology
Essex Bio-Technology is a biopharmaceutical company primarily engaged in the research, development, manufacture, and commercialization of bio-pharmaceutical products. The company focuses on the fields of ophthalmology and dermatology, offering a range of therapeutic products aimed at treating various conditions related to these sectors. Its core products include bioactive molecules for wound healing and tissue repair, which are distributed across various regions including Asia and Europe.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Sihuan Pharmaceutical Holdings Group
―
Consun Pharmaceutical Group Ltd.
―
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
―
China Shineway Pharmaceutical Group Limited
―
Ownership Overview
―
Insiders
0.60%
Mutual Funds
― Other Institutional Investors
99.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---